Immune reactions to Pityrosporum ovale in adult patients with atopic and seborrheic dermatitis.
M Kieffer, IM Bergbrant, J Faergemann, GB Jemec, V … - J Am Acad Dermatol, 1990 - ncbi.nlm.nih.gov
J Am Acad Dermatol. 1990 May;22(5 Pt 1):739-42. Immune reactions to Pityrosporum
ovale in adult patients with atopic and seborrheic dermatitis. ...

QUANTITATIVE MICROBIOLOGY OF THE SCALP IN NON-DANDRUFF, DANDRUFF, AND SEBORRHEIC DERMATITIS. -
KJ McGinley, JJ Leyden, RR Marples, MRC Path, AM … - Journal of Investigative Dermatology, 1975 - nature.com
... 1523-1747.ep12512335. QUANTITATIVE MICROBIOLOGY OF THE SCALP IN NON-DANDRUFF,
DANDRUFF, AND SEBORRHEIC DERMATITIS. Kenneth J McGinley ...

The primary histologic lesion of seborrheic dermatitis and psoriasis.
H Pinkus, AH Mehregan - J Invest Dermatol, 1966 - ncbi.nlm.nih.gov
J Invest Dermatol. 1966 Jan;46(1):109-16. The primary histologic lesion of
seborrheic dermatitis and psoriasis. Pinkus H, Mehregan AH. ...

Seborrheic dermatitis in patients with acquired immunodeficiency syndrome. -
BM Mathes, MC Douglass - J Am Acad Dermatol, 1985 - ncbi.nlm.nih.gov
J Am Acad Dermatol. 1985 Dec;13(6):947-51. Seborrheic dermatitis in patients with
acquired immunodeficiency syndrome. Mathes BM, Douglass MC. ...

… of Pityosporum ovale density with clinical severity of seborrheic dermatitis as assessed by a …
MC Heng, CL Henderson, DC Barker, G Haberfelde - J Am Acad Dermatol, 1990 - ncbi.nlm.nih.gov
1990 Jul;23(1):82-6. Correlation of Pityosporum ovale density with clinical severity
of seborrheic dermatitis as assessed by a simplified technique. ...

Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. -
RB Skinner Jr, PW Noah, RM Taylor, MD Zanolli, S … - J Am Acad Dermatol, 1985 - ncbi.nlm.nih.gov
Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. Skinner
RB Jr, Noah PW, Taylor RM, Zanolli MD, West S, Guin JD, Rosenberg EW. ...

Seborrheic-like dermatitis of acquired immunodeficiency syndrome. A clinicopathologic study. -
FF Soeprono, RA Schinella, CJ Cockerell, SL Comite - J Am Acad Dermatol, 1986 - ncbi.nlm.nih.gov
... skin biopsies from twenty-one patients with acquired immunodeficiency syndrome or
its prodrome who presented with the "seborrheic dermatitis" associated with ...

… , Malassezia yamatoensis, Isolated from a Patient with Seborrheic Dermatitis, and Its Distribution … -
T Sugita, M Tajima, M Takashima, M Amaya, M Saito, … - MICROBIOLOGY and IMMUNOLOGY, 2004 - J-STAGE
... a Patient with Seborrheic Dermatitis, and Its ... Key words: Malassezia yamatoensis,
New species, Seborrheic dermatitis, Microflora 579 Microbiol. ...

Management of Seborrheic Dermatitis and Pityriasis Versicolor. -
J Faergemann - American Journal of Clinical Dermatology, 2000 - dermatology.adisonline.com
... 80. Management of Seborrheic Dermatitis and Pityriasis Versicolor. [Disease
Management]. Faergemann, Jan. ... Seborrheic Dermatitis TOP. Seborrheic ...

An open pilot study using tacrolimus ointment in the treatment of seborrheic dermatitis -
A Meshkinpour, J Sun, G Weinstein - Journal of the American Academy of Dermatology, 2003 - Elsevier
... the treatment of seborrheic dermatitis Azin ... Seborrheic dermatitis is generally
treated with topical steroids, antifungals, or both. This ...

MONDAY, July 31 (HealthDay News) -- Barrier Therapeutics' treatment for seborrheic dermatitis has been approved by the U.S. Food and Drug Administration, the company said in a statement.

Xolegel (2% ketoconazole, USP) is a once-daily topical gel to treat the skin condition, characterized by a red, scaly, itchy rash that primarily develops on the face, scalp, hairline, eyebrows and trunk.

Seborrheic dermatitis affects 3 percent to 5 percent of the U.S. population, or about 8.5 million people, the company said. The condition often recurs, requiring additional treatment.

More information

To learn more about seborrheic dermatitis, visit the American Academy of Family Physicians.